All lobbying filings
ACG Advocacy
ACG Advocacy filed a Q3 report for Amgen USA Inc. on October 20, 2026, reporting $50,000 in lobbying income.
Lobbying for Amgen USA Inc. · Human Therapeutics/Biotechnology firm.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
California
Lobbyists on this filing
1
-
MANUS COONEYPreviously held: Staff Director & Chief Counsel, Senate Judiciary Committee
Government bodies contacted
2
Lobbying activity
1
Patent policy.